Posts

PSE Prostate Cancer Test is 270% Better Than PSA

Image
This Prostate Cancer Test is 270% Better Than PSA - YouTube Blood Test Achieves 94% Accuracy in Prostate Cancer Detection, Potentially Reducing Unnecessary Biopsies by Nearly 80% Major breakthrough in epigenetic testing shows promise for revolutionizing PSA-based screening By the Informed Prostate Cancer Support Group A novel blood test combining traditional PSA screening with advanced epigenetic analysis has demonstrated 94% accuracy in detecting prostate cancer—more than doubling the reliability of PSA testing alone—according to multiple peer-reviewed studies published since 2023. The EpiSwitch Prostate Screening (PSE) test, developed through collaboration between Oxford BioDynamics PLC, Imperial College London, and the University of East Anglia, has now shown in real-world clinical settings that it could reduce unnecessary biopsies by up to 79%. For the estimated 120,000 men in the UK and hundreds of thousands more in the United States who undergo prostate biopsies annually des...
Post a Comment
Read more

A doctor's own prostate cancer recovery

Image
A doctor's own prostate cancer recovery NEWSLETTER ARTICLE From Doctor to Patient: A Physiatrist's Journey Through Prostate Cancer Recovery Highlights Critical Gap in Pelvic Floor Rehabilitation Growing Evidence Supports Comprehensive Prehabilitation and Early Intervention Programs For the IPCSG Newsletter When Francisco M. Torres, MD, an interventional physiatrist specializing in spine-related pain syndromes, was diagnosed with prostate cancer this past summer, his three decades of medical experience did not fully prepare him for what followed. His journey from physician to patient has illuminated a significant gap in prostate cancer care that recent research confirms affects thousands of men annually: the systematic neglect of pelvic floor rehabilitation in perioperative planning. Dr. Torres underwent robot-assisted radical prostatectomy for his less aggressive prostate cancer. What he discovered during his recovery has prompted him to advocate publicly for fundamental c...
Post a Comment
Read more

Targeting Protective Enzymes Could Overcome Prostate Cancer Treatment Resistance

Image
Hidden weakness makes prostate cancer self-destruct | ScienceDaily International study identifies molecular mechanism that helps tumors resist therapy—and shows how to exploit it Scientists have discovered a critical vulnerability in prostate cancer cells that could revolutionize treatment for the disease, particularly for patients whose tumors have become resistant to current therapies. The breakthrough centers on two enzymes that act as molecular bodyguards for cancer cells—and blocking them makes existing treatments work dramatically better. The discovery comes at a crucial time. Prostate cancer incidence rates have reversed from a decline of 6.4% per year during 2007-2014 to an increase of 3.0% annually during 2014-2021, with the steepest increases in advanced-stage disease. An estimated 313,780 new cases will be diagnosed in 2025, with approximately 35,770 men expected to die from the disease. The Resistance Problem While modern androgen receptor inhibitors like enzalutamide ...
Post a Comment
Read more

Understanding Provenge (sipuleucel-T): A Patient’s Guide

Image
Dr. Paul Dato, MD - Provenge Immunotherapy Dr. Dato presented a talk at the October IPCSG meeting. Dendreon, who sponsored this presentation required that no recording be made. Here are some notes on the topic presented. Linked above is a prior presentation in May of 2023 on Provenge by Dr. Jim Hsiang, and what follows is a summary of that presentation. Revolutionary Treatment Harnesses Body's Own Immune System Dr. Jim Tsang, a radiation oncologist from Corpus Christi Urology Group and Cancer Center, explained how Provenge represents a fundamentally different approach to fighting prostate cancer. "This is personalized medicine at its finest," Dr. Tsang told the audience. "We're using your own immune cells to train your body to recognize and attack cancer cells." Unlike traditional treatments, Provenge does not lower PSA levels—a concept Dr. Tsang emphasized multiple times. "For the first time, we're asking you to reprogram your thinking about PSA,...
Post a Comment
Read more

Items of Interest

Image
  PROSTATE CANCER CARE ACHIEVEMENTS October 2025 An Informed Prostate Cancer Support Group Newsletter Special Edition Dear Support Group Members, October 2025 will be remembered as a watershed month in prostate cancer care. We witnessed an unprecedented convergence of scientific breakthroughs, regulatory approvals, and technological innovations that are fundamentally changing how we detect, diagnose, and treat prostate cancer. This comprehensive report brings you detailed, patient-friendly information about these remarkable advances. From life-extending drug combinations that cut death risk by 40% to artificial intelligence tools that catch cancers pathologists might miss, from immunotherapy breakthroughs to precision medicine advances tailored to your unique genetic profile—the progress is nothing short of extraordinary. What makes these advances even more meaningful is that they're not just happening in laboratories—they're making their way into clinics where they can help re...
Post a Comment
Read more